有氧双重任务对帕金森病的处理速度和注意力的急性影响:随机对照试验研究
Irimia Mollinedo-Cardalda1, Esther Monge-Pereira1, Karina Pitombeira Pereira-Pedro2
1Department of Functional Biology and Health Sciences, Faculty of Physiotherapy, Isaúde Research Group, University of Vigo. Spain; FisioIsaúde Research Group, Galicia Sur Health Research Institute (II Galicia Sur), SERGAS-UVIGO, Spain.
Journal of bodywork and movement therapies
|November 29, 2025
概括
双重任务 (DT) 循环改善了帕金森病 (PD) 患者的信息处理速度. 这种安全的干预,结合了身体和认知任务,有利于患有PD和不同认知状态的人.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 认知科学 认知科学
背景情况:
- 帕金森病 (PD) 显著损害功能,特别是在双重任务 (DT) 的表现.
- 对DT活动的困难会影响PD患者的日常生活和生活质量.
研究的目的:
- 评估有氧自行车DT对帕金森病患者处理速度和注意力的直接影响.
- 调查联合身体和认知干预对PD认知功能的影响.
主要方法:
- 一个随机对照试验,涉及帕金森病患者 (2-3阶段).
- 干预组进行了MOTOmed Viva 2帕金森循环,实验组增加了一个认知任务 (定向,记忆,计算,语言,相似性).
- 评估的变量包括认知状态 (迷你心理状态检查) 和处理速度 (符号数字模式测试).
主要成果:
- 控制组和实验组在符号数字模式测试中都显示出显著的改善.
- 与对照组 (中等到大) 相比,实验组表现出更大的效果大小 (大到非常大).
- 没有认知障碍的参与者表现出显著的改善,效果大小非常大,无论分组分配如何.
结论:
- 在MOTOmed设备上使用双任务自行车是帕金森病患者 (2-3阶段) 的安全干预措施,包括那些有轻度至中度认知障碍的人.
- 将骑自行车与认知任务相结合,似乎可以提高帕金森病患者的信息处理速度.
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


